Dow Jones Top Company Headlines at 1 PM ET: Meta Directors, Shareholders Settle Privacy Suit Before Board Members Testify at Trial | FDA ...

Dow Jones
Jul 18, 2025

Meta Directors, Shareholders Settle Privacy Suit Before Board Members Testify at Trial

With a settlement, current and former board leaders avoid having to take the stand in a lawsuit over their response to the Cambridge Analytica scandal.

----

FDA Authorizes Juul's E-Cigarettes, Reversing Ban That Nearly Bankrupted Firm

The regulator authorized the company to keep its e-cigarettes on the U.S. market after a federal ban in 2022 had pushed the company to the brink of bankruptcy.

----

GE Aerospace Raises Guidance on Tariff-Resilient Engine Demand

GE Aerospace raised its full-year earnings outlook and beat expectations on its top and bottom lines in the second quarter.

----

PepsiCo Revenue Rises Despite Lower North America Volumes

PepsiCo said its business remained resilient during the second quarter, logging higher revenue despite a small drop in sales volumes.

----

Bristol-Myers and Pfizer to Offer Blockbuster Blood Thinner at Discount

The joint venture is launching a direct-to-consumer service of Eliquis after discussions with the Trump administration.

----

U.S.-Based Wells Fargo Banker Blocked From Leaving China

Chinese authorities have placed an exit ban on a China-born executive after she entered the country recently. The bank has suspended travel to China.

----

ArcBest CEO Judy McReynolds to Retire

Seth Runser, president of the trucking and logistics company, will take over in 2026.

----

TSMC to Speed Up Arizona Expansion to Meet Soaring Chip Demand

The world's largest contract chip maker's robust results are the latest sign that the AI wave remains strong.

----

Abbott Labs Pares Outlook After Profit, Sales Gains

The healthcare-products maker trimmed and narrowed its guidance for the year while reporting strong profit and sales gains in the second quarter.

----

Canadian Suitor of 7-Eleven Owner Abandons Its Multiyear, $47 Billion Bid

Couche-Tard said Seven & i's leadership hasn't cooperated in meetings and has withheld information needed to close the deal.

----

U.S. Bancorp Second-Quarter Profit Rises Despite Soft Interest Income

U.S. Bancorp notched a higher profit for the latest quarter, though interest income growth was more sluggish than anticipated.

----

Travelers Stock Is Rising as the Insurer Smashes Earnings Expectations

The property and casualty insurer reports core earnings of $6.51 a share for the second quarter.

----

Volvo Car Swings to Net Loss on Hit From Restructuring and Impairments Charges

The company is confronting growing market uncertainties that have weighed on volumes, increased price pressure and tariffs hitting profits.

----

Samsung Leader Sheds Legal Woes After Yearslong Battle

Chairman Lee Jae-yong, a powerful figure in global tech, saw his acquittal of multiple charges upheld at a sensitive time for the conglomerate.

----

A Bright Spot for Biotech in Trump's Megabill

Folded into the blockbuster law that passed this month was the Orphan Cures Act, a measure that spares drugs approved for more than one orphan disease from Medicare price negotiation.

----

Intel's Fall Was Decades In the Making

New CEO Lip-Bu Tan has launched another large workforce reduction in 2025.

 

(END) Dow Jones Newswires

July 17, 2025 13:00 ET (17:00 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10